Landscapes / Companies
Bukwang Pharmaceutical not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 5 in all
Trials
1 active
7 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Atypical antipsychotic |
Approved in other | Oct 2027Phase 3 trial completes | |||
| Next date | Oct 2027 · Phase 3 trial completes | ||||
| Also tested for | Major Depressive Disorder (MDD), Major Depressive Disorder With Psychotic Features | ||||
| Open drug page | |||||
About
- No active trial
- Apatinib mesylate, Clevudine, JM-010, SOL-804-F
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021